Ngm Biopharmaceuticals shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Ngm Biopharmaceuticals (NGM) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Ngm Biopharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Ngm Biopharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ngm Biopharmaceuticals by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $333k | 209k | 1.59 |
| 2023-12-31 | $95k | 111k | 0.86 |
| 2023-09-30 | $293k | 273k | 1.07 |
| 2023-06-30 | $613k | 237k | 2.59 |
| 2023-03-31 | $779k | 191k | 4.08 |
| 2022-12-31 | $1.9M | 380k | 5.02 |
| 2022-06-30 | $2.2M | 172k | 12.82 |
| 2022-03-31 | $2.5M | 164k | 15.25 |
| 2021-12-31 | $3.7M | 207k | 17.71 |
| 2021-09-30 | $5.3M | 252k | 21.02 |
| 2021-03-31 | $1.5M | 51k | 29.07 |
| 2020-12-31 | $1.5M | 48k | 30.28 |
| 2020-09-30 | $845k | 53k | 15.91 |
| 2020-06-30 | $1.2M | 60k | 19.75 |
| 2019-12-31 | $1.6M | 87k | 18.49 |
| 2019-09-30 | $755k | 55k | 13.85 |
| 2019-06-30 | $823k | 56k | 14.64 |